Figure 1.

Colorectal cancer hazard ratios and 95% confidence intervals from WHI clinical trial and observational study for conjugated equine estrogen (CEE) and for CEE plus medroxyprogesterone acetate (MPA), according to three aspects of extent of disease at diagnosis.